Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Upon the aberrant activation of oncogenes, normal cells can enter the cellular senescence program, a state of stable cell-cycle arrest, which represents an important barrier against tumour development in vivo. Senescent cells communicate with their environment by secreting various cytokines and growth factors, and it was reported that this 'secretory phenotype' can have pro- as well as anti-tumorigenic effects. Here we show that oncogene-induced senescence occurs in otherwise normal murine hepatocytes in vivo. Pre-malignant senescent hepatocytes secrete chemo- and cytokines and are subject to immune-mediated clearance (designated as 'senescence surveillance'), which depends on an intact CD4(+) T-cell-mediated adaptive immune response. Impaired immune surveillance of pre-malignant senescent hepatocytes results in the development of murine hepatocellular carcinomas (HCCs), thus showing that senescence surveillance is important for tumour suppression in vivo. In accordance with these observations, ras-specific Th1 lymphocytes could be detected in mice, in which oncogene-induced senescence had been triggered by hepatic expression of Nras(G12V). We also found that CD4(+) T cells require monocytes/macrophages to execute the clearance of senescent hepatocytes. Our study indicates that senescence surveillance represents an important extrinsic component of the senescence anti-tumour barrier, and illustrates how the cellular senescence program is involved in tumour immune surveillance…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given the proinflammatory nature of the SASP, it is not surprising that senescent cells can attract immune cells, including destructive leukocytes of the innate and adaptive immune systems (131, 132, 135).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Among the cells that participate in the clearance of senescent cells are natural killer cells, macrophages, and T cells (131, 135, 139).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Senescent cells, presumably by virtue of SASP-derived factors, can stimulate the infiltration of leukocytes (93, 131, 132), which produce reactive toxic moieties that can cause DNA damage.”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Another function appears to be the stimulation of a local immune reaction to eliminate oncogene-expressing cells, both those cells that have undergone oncogene-induced senescence and those oncogene-transformed cells that have bypassed or escaped senescence (131).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“The surveillance and clearance of senescent cells by the immune system is necessary in order to limit tumorigenesis in premalignant lesions and following cancer therapy155,156,159.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [156]
39 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801
Self-citationKrtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Khwaja, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2783 · Cited by 1,039
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
Sage, J., Miller, A. L., Pérez-Mancera, P. A., Wysocki, J. M., & Jacks, T. (2003) · Nature · doi:10.1038/nature01764 · Cited by 538
Frid, M. G., Brunetti, J. A., Burke, D. L., Carpenter, T. C., Davie, N. J., Reeves, J. T., Roedersheimer, M. T., van Rooijen, N., & Stenmark, K. R. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050599 · Cited by 449
Silva, M. T. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809549 · Cited by 322
Cited by
Items 601–700 of 1,009
Oncogenic senescence: a multi-functional perspective
Baker, D. J., Alimirah, F., van Deursen, J. M., Campisi, J., & Hildesheim, J. (2017) · Oncotarget · doi:10.18632/oncotarget.15742 · Cited by 45
“Consistent with these findings, senescence-induced immune surveillance is also relevant to the elimination of pre-malignant NRasG12V lesions [34].”
van Tuyn, J., Jaber-Hijazi, F., MacKenzie, D., Cole, J. J., Mann, E., Pawlikowski, J. S., Rai, T. S., Nelson, D. M., McBryan, T., Ivanov, A., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.05.030 · Cited by 51
“However, clearance of mouse hepatocytes expressing an activated NrasQ61K oncogene was also shown to depend on activation of adaptive immunity, specifically on CD4þ T cells (Kang et al., 2011).”
BackgroundMa, C., Zhang, Q., & Greten, T. F. (2017) · FEBS Journal · doi:10.1111/febs.14209 · Cited by 54
NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesis
Luiken, S., Fraas, A., Bieg, M., Sugiyanto, R. N., Goeppert, B. F., Singer, S., Ploeger, C., Warsow, G., Marquardt, J. U., Sticht, C., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1198-3 · Cited by 52
Self-citationLiu, P., Tang, Q., Chen, M., Chen, W., Lu, Y., Liu, Z., & He, Z. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.589908 · Cited by 56
“In another study, hepatocytes with the overexpression of Ras rapidly underwent protooncogene-induced senescence, and meanwhile secreted SASP factors to activate immune system to remove themselves, thus restricting the occurrence of HCC (13).”
BackgroundInfluentialSIRT1 counteracted the activation of STAT3 and NF-κB to repress the gastric cancer growth.
Lu, J., Zhang, L., Chen, X., Lu, Q., Yang, Y., Liu, J., & Ma, X. (2014) · PubMed Central · Cited by 58
Regulation of cancer stem cell activities by tumor-associated macrophages.
Jinushi, M., Baghdadi, M., Chiba, S., & Yoshiyama, H. (2012) · Europe PMC (PubMed Central) · Cited by 56
Targeting CDK4/6 for Anticancer Therapy
Qi, J., & Ouyang, Z. (2022) · Biomedicines · doi:10.3390/biomedicines10030685 · Cited by 53
“The other remarkable feature of senescence is SASP, which stimulates the immune clearance of senescent cells [60].”
BackgroundMechanisms involved in hematopoietic stem cell aging
Fujino, T., Asada, S., Goyama, S., & Kitamura, T. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04356-5 · Cited by 56
Aging unconventionally: γδ T cells, iNKT cells, and MAIT cells in aging
Kurioka, A., & Klenerman, P. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101816 · Cited by 51
“Finally, the accumulation of senescent cells with age contributes to the chronically inflamed inflammaging environment observed in old age, which in turn drive the progression of age-related diseases [347, 348].”
BackgroundRichardson, M., & Richardson, D. R. (2023) · Molecular Pharmacology · doi:10.1124/molpharm.123.000803 · Cited by 51
Immune surveillance of senescence: potential application to age-related diseases
Wang, T., & Nakanishi, M. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2024.06.007 · Cited by 54
Chen, C., Yang, R., & Xu, H. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01803-1 · Cited by 49
The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective
Muynck, K. D., Vanderborght, B., Vlierberghe, H. V., & Devisscher, L. (2021) · Cells · doi:10.3390/cells10112959 · Cited by 53
“In this setting, following CCL2 secretion, pre-malignant hepatocytes were cleared by recruited CCR2+ pro-inflammatory MoMFs, thereby preventing HCC initiation [371,372].”
BackgroundIshtiaq, S. M., Arshad, M. I., & Khan, J. A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108298 · Cited by 49
Wilmouth, J., Olabe, J., García-García, D., Lucas, C., Guiton, R., Roucher‐Boulez, F., Dufour, D., Damon‐Soubeyrand, C., Sahut‐Barnola, I., Pointud, J., et al. (2022) · Science Advances · doi:10.1126/sciadv.add0422 · Cited by 50
Neutrophil extracellular traps and long COVID
Shafqat, A., Omer, M. H., Albalkhi, I., Razzak, G. A., Abdulkader, H. S., Rab, S. A., Sabbah, B. N., AlKattan, K. M., & Yaqinuddin, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1254310 · Cited by 53
Armandi, A., Rosso, C., Caviglia, G. P., & Bugianesi, E. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156080 · Cited by 53
Recent Advances in Aging and Immunosenescence: Mechanisms and Therapeutic Strategies
Wang, S., Huo, T., Lu, M., Zhao, Y., Zhang, J., He, W., & Chen, H. (2025) · Cells · doi:10.3390/cells14070499 · Cited by 57
“Many studies have shown that the immune system can clear SCs induced by various causes [25,30,39].”
Mechanisms driving the ageing heart
Anderson, R., Richardson, G. D., & Passos, J. F. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2017.10.015 · Cited by 46
Liu, Y., Tseng, T., Soong, R., Peng, C.-Y., Cheng, Y.-H., Huang, S.-F. K., Chuang, T., Kao, J., & Huang, L. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0462-3 · Cited by 49
Cellular senescence and hematological malignancies: From pathogenesis to therapeutics
Hu, D., Yuan, S., Zhong, J., Liu, Z., Wang, Y., Liu, L., Li, J., Wen, F., Liu, J., & Zhang, J. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107817 · Cited by 49
Senescence, NK cells, and cancer: navigating the crossroads of aging and disease
Gergues, M., Bari, R., Koppisetti, S., Gosiewska, A., Kang, L., & HARIRI, R. J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1565278 · Cited by 52
Alterations in Ca2+ Signalling via ER-Mitochondria Contact Site Remodelling in Cancer
Kerkhofs, M., Giorgi, C., Marchi, S., Seitaj, B., Parys, J. B., Pinton, P., Bultynck, G., & Bittremieux, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4567-7_17 · Cited by 50
Alexander, E., Hildebrand, D. G., Kriebs, A., Obermayer, K., Manz, M., Rothfuss, O., Essmann, F., & Schulze-Osthoff, K. (2013) · Journal of Cell Science · doi:10.1242/jcs.128835 · Cited by 44
“Finally, these cytokines or other secreted factors have been shown to attract immune cells in an inflammatory response, leading to the elimination of senescent tumor cells (Kang et al., 2011; Xue et al., 2007; Hoenicke and Zender, 2012).”
BackgroundSenescent cells limit p53 activity via multiple mechanisms to remain viable
Sturmlechner, I., Sine, C. C., Jeganathan, K. B., Zhang, C., Fierro Velasco, R. O., Baker, D. J., Li, H., & van Deursen, J. M. (2022) · Nature Communications · doi:10.1038/s41467-022-31239-x · Cited by 45
Effect of Cellular Senescence on the Growth of HER2-Positive Breast Cancers
Zacarias-Fluck, M. F., Morancho, B., Vicario, R., Luque Garcia, A., Escorihuela, M., Villanueva, J., Rubio, I. T., & Arribas, J. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv020 · Cited by 45
Kalathur, M., Toso, A., Chen, J., Revandkar, A., Danzer-Baltzer, C., Guccini, I., Alajati, A., Sarti, M., Pinton, S., Brambilla, L., et al. (2015) · Nature Communications · doi:10.1038/ncomms8227 · Cited by 44
A tale of the good and bad: Cell senescence in bone homeostasis and disease
(2019) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.03.005 · Cited by 45
Re, O. L., Mazza, T., Giallongo, S., Sanna, P., Rappa, F., Luong, T. V., Volti, G. L., Drovakova, A., Roskams, T., Haele, M. V., et al. (2019) · Theranostics · doi:10.7150/thno.35045 · Cited by 47
The dichotomous role of TGF-β in controlling liver cancer cell survival and proliferation
Zhang, K., Zhang, M., Luo, Z., Wen, Z., & Yan, X. (2020) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2020.09.005 · Cited by 46
Soriani, A., Fionda, C., Ricci, B., Iannitto, M. L., Cippitelli, M., & Santoni, A. (2013) · OncoImmunology · doi:10.4161/onci.26663 · Cited by 48
Li, D., de Glas, N. A., & Hurria, A. (2015) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2015.08.003 · Cited by 48
“cent cells may also result in decreased tissue integrity and possibly contribute to cancer development.(51,52)”
BackgroundDoorduijn, E. M., Sluijter, M., Salvatori, D. C. F., Silvestri, S., Maas, S., Arens, R., OSSENDORP, F. A., van der Burg, S. H., & van Hall, T. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0334 · Cited by 50
“Another mechanism by which tumorspecific CD4þ T cells could mediate direct tumor control is through induction of tumor cell senescence through the production of cytokines intratumorally (38, 39).”
BackgroundCellular senescence in tissue repair: every cloud has a silver lining
Yun, M. H. (2018) · The International Journal of Developmental Biology · doi:10.1387/ijdb.180081my · Cited by 41
Lung regeneration: implications of the diseased niche and ageing
Melo-Narváez, M. C., Stegmayr, J., Wagner, D. E., & Lehmann, M. (2020) · European Respiratory Review · doi:10.1183/16000617.0222-2020 · Cited by 46
PTEN deletion in luminal cells of mature prostate induces replication stress and senescence in vivo
Parisotto, M., Grelet, E., El Bizri, R., Dai, Y., Terzic, J., Eckert, D., Gargowitsch, L., Bornert, J.-M., & Metzger, D. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171207 · Cited by 43
“Oncogene-induced senescence (OIS), by permanently halting cell proliferation and promoting immune surveillance of premalignant lesions, is a barrier against cell transformation (Braig et al., 2005; Chen et al., 2005; Kang et al., 2011).”
BackgroundSpatial resolution of cellular senescence dynamics in human colorectal liver metastasis
Garbarino, O., Lambroia, L., Basso, G., Marrella, V., Franceschini, B., Soldani, C., Pasqualini, F., Giuliano, D., Costa, G., Peano, C., et al. (2023) · Aging Cell · doi:10.1111/acel.13853 · Cited by 43
“Senescent cancer cells might also promote immune recruitment for their suicide or signal for the clearance of non- senescent cancer cells through their secretome (Kang et al., 2011; Xue et al., 2007).”
BackgroundAutophagy and senescence: the molecular mechanisms and implications in liver diseases
Li, Q., Lin, Y., Liang, G., Xiao, N., Zhang, H., Yang, X., Yang, J., & Liu, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316880 · Cited by 43
“In the early stage of tumor development, senescence can inhibit tumorigenesis of liver cancer cells by eradicating premalignant hepatocytes [136].”
BackgroundInfluentialTelomere Length: A Cardiovascular Biomarker and a Novel Therapeutic Target
Sagris, Μ., Theofilis, P., Antonopoulos, A. S., Tsioufis, K. P., & Tousoulis, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416010 · Cited by 49
NETosis : Sculpting tumor metastasis and immunotherapy
Hu, Y., Wang, H., & Liu, Y. (2023) · Immunological Reviews · doi:10.1111/imr.13277 · Cited by 50
“17 Hepatocytes function primarily by secreting factors modulating cellular proliferation, metabolism, cell- to-cell crosstalk, etc 132 As HCC progresses, the dynamic changes of hepatocyte secretomes are both the result and cause of tumorigenesis.”
BackgroundDeregulated transcription factors in the emerging cancer hallmarks
Hasan, A., Khan, N. A., Shahab Uddin, M. S., Khan, A. Q., & Steinhoff, M. S. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.12.001 · Cited by 48
Xue, H., Zhao, B., Towers, M., Liao, L., Luzete-Monteiro, E., Xu, X., Freeman, C., Peng, H., Tang, H., Havas, A. P., et al. (2024) · Nature Aging · doi:10.1038/s43587-023-00564-1 · Cited by 44
“3i–l), consistent with immune-mediated clearance of NRAS-expressing senescent cells 29 .”
InfluentialDysregulated serum response factor triggers formation of hepatocellular carcinoma
Ohrnberger, S., Thavamani, A., Braeuning, A., Lipka, D. B., Kirilov, M., Geffers, R., Authenrieth, S. E., Römer, M., Zell, A., von Bonin, M., et al. (2015) · Hepatology · doi:10.1002/hep.27539 · Cited by 49
Self-citationInflammatory signaling in genomically instable cancers
Talens, F., & van Vugt, M. A. T. M. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1638192 · Cited by 43
“The secretion of SASP cytokines facilitates immune cell recruitment, as part of an attempt to eliminate possibly pre-malignant cells, thereby providing a cell-intrinsic surveillance mechanism with tumor-suppressive capacity [102,103].”
BackgroundA guide to senolytic intervention in neurodegenerative disease
Lee, S., Wang, E. Y., Steinberg, A. B., Walton, C. C., Chinta, S. J., & Andersen, J. K. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111585 · Cited by 39
Resident macrophages of the lung and liver: The guardians of our tissues
Kulle, A., Thanabalasuriar, A., Cohen, T. S., & Szydlowska, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1029085 · Cited by 46
Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis
Suk, K. T., Mederacke, I., Gwak, G., Cho, S. W., Adeyemi, A., Friedman, R. A., & Schwabe, R. F. (2016) · Gut · doi:10.1136/gutjnl-2015-310212 · Cited by 50
Ploeger, C., Waldburger, N., Fraas, A., Goeppert, B. F., Pusch, S., Breuhahn, K., Wang, X. W., Schirmacher, P., & Roessler, S. K. (2016) · Hepatology · doi:10.1002/hep.28684 · Cited by 50
“A mouse model of NRas-induced senescent hepatocytes demonstrated that CD4 T cell-mediated immune clearance of premalignant senescent cells is crucial to suppress liver cancer development.((48)) Therefore, both CD8-positive cytotoxic and CD4-positive regulatory T cells are required for immune surveillance, and it is co…”
Self-citationJames, E. L., Lane, J. A. E., Michalek, R. D., Karoly, E. D., & Parkinson, E. K. (2016) · Scientific Reports · doi:10.1038/srep38489 · Cited by 40
Dulic, V. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_2 · Cited by 42
Ramirez, C. F. A., Taranto, D., Ando‐Kuri, M., de Groot, M. H. P., Tsouri, E., Huang, Z., de Groot, D., Kluin, R. J. C., Kloosterman, D. J., Verheij, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46835-2 · Cited by 46
Cellular senescence in liver diseases: From molecular drivers to therapeutic targeting
Du, K., Umbaugh, D. S., Ren, N., & Diehl, A. M. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.08.021 · Cited by 49
Aging tumour cells to cure cancer: “pro-senescence” therapy for cancer
Calcinotto, A., & Alimonti, A. (2017) · Swiss Medical Weekly · doi:10.57187/smw.2017.14367 · Cited by 46
Cellular senescence: from anti-cancer weapon to anti-aging target
Yuan, L., Alexander, P. B., & Wang, X. (2020) · Science China Life Sciences · doi:10.1007/s11427-019-1629-6 · Cited by 43
“Consequently, an increased catabolism-to-anabolism ratio along with high levels of mitochondrial ROS together establish a metabolic state less supportive for proliferation (Kaplon et al., 2013).”
BackgroundXia, Y., Brown, Z. J., Huang, H., & Tsung, A. (2021) · Cancer Medicine · doi:10.1002/cam4.4177 · Cited by 48
Wong, G. C., & Chow, H. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220203 · Cited by 48
Effects of senescence on the tumour microenvironment and response to therapy
Reynolds, L. E., Maallin, S., Haston, S., Martínez-Barberá, J. P., Hodivala‐Dilke, K., & Pedrosa, A. (2023) · FEBS Journal · doi:10.1111/febs.16984 · Cited by 45
“NK cells, macrophages, CD8 + T cells and other immune cells [110,111] are involved in the anti-senescence function to prevent tumour progression [112].”
Enhancing immunity during ageing by targeting interactions within the tissue environment
Bracken, O. V., Maeyer, R. P. H. D., & Akbar, A. N. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01126-9 · Cited by 46
“Both senescent T cells and NK cells can eliminate senescent stromal cells in an antigen-independent manner 102,103 .”
Jin, J., Zhu, P., Liao, Y., Li, J., Liao, W., & He, S. (2015) · Oncotarget · doi:10.18632/oncotarget.4265 · Cited by 42
“CD4+ T lymphocyte cells play a “sensing” role in detecting premalignant tumor cells and then regulate their eradication, which can hinder the occurrence and development of hepatocellular cancer [37].”
BackgroundTazzari, M., Indio, V., Vergani, B., Cecco, L. D., Rini, F., Negri, T., Camisaschi, C., Fiore, M., Stacchiotti, S., Dagrada, G. P., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.06.634 · Cited by 45
Legumain-deficient macrophages promote senescence of tumor cells by sustaining JAK1/STAT1 activation
Shen, L., Kang, L., Wang, D., Xun, J., Chen, C., Du, L., Zhang, M., Gong, J., Mi, X., Yue, S., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.12.013 · Cited by 41
The Role of Ageing and Parenchymal Senescence on Macrophage Function and Fibrosis
Campbell, R., Docherty, M.-H., Ferenbach, D. A., & Mylonas, K. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.700790 · Cited by 47
“Chronic senescence is marked by senescent cells that accumulate with age and chronic diseases, such as pre-cirrhotic fibrosis of livers (36, 37) and chronic kidney disease in which senescent cell accumulation correlates to increased disease severity (38) Accumulation of senescent cells also contributes to radiation to…”
BackgroundActivatable senoprobes and senolytics: Novel strategies to detect and target senescent cells
Morsli, S., Doherty, G. J., & Muñoz-Espín, D. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111618 · Cited by 42
Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges
Teng, Y., Xie, S., Guo, P.-P., Deng, Z., Zhang, Z., Gao, W., Zhang, W., & Zhong, J. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00586 · Cited by 48
Estepa‐Fernández, A., García‐Fernández, A., Lérida‐Viso, A., Blandez, J. F., Galiana, I., Sancenón, F., Orzáez, M., & Martínez‐Máñez, R. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106628 · Cited by 44
Immunosurveillance of senescent cancer cells by natural killer cells
Iannello, A., & Raulet, D. H. (2014) · OncoImmunology · doi:10.4161/onci.27616 · Cited by 40
Novel PET Imaging Probe for Quantitative Detection of Senescence In Vivo
Xiang, X., Dong, C., Zhou, L., Liu, J., Rabinowitz, Z. M., Zhang, Y., Guo, H., He, F., Chen, X., Wang, Y., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00179 · Cited by 41
Zhao, M., Huang, H., He, F., & Fu, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1188277 · Cited by 47
“Monocyte-derived macrophages help CD4+ T cells remove senescent premalignant hepatocytes, thus inhibiting hepatocarcinogenesis (62).”
BackgroundEmerging Roles of Vitamin B12 in Aging and Inflammation
Simonenko, S. Y., Bogdanova, D. A., & Kuldyushev, N. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25095044 · Cited by 45
“In that respect, SASP is considered to be a beneficial response of senescent cells in organisms [156,157].”
BackgroundThe extent of liver injury determines hepatocyte fate toward senescence or cancer
Wang, C., Chen, W., Wu, Y., You, P., Zheng, S., Liu, C.-C., Xiang, D., Wang, M., Cai, Y., Zhao, Q., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0622-x · Cited by 41
Tipping the Scales With Zebrafish to Understand Adaptive Tumor Immunity
Miao, K., Kim, G., Meara, G. K., Qin, X., & Feng, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.660969 · Cited by 49
“with myeloid cells to prevent the development of liver cancer (Kang et al., 2011).”
BackgroundUceda-Castro, R., Margarido, A. S., Cornet, L., Vegna, S., Hahn, K., Song, J., Putavet, D. A., van Geldorp, M., Çitirikkaya, C. H., de Keizer, P. L. J., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100821 · Cited by 43
“Senescent cells are not cleared by infiltrated T cells upon chemotherapy Intricate crosstalk between immune cells and senescent cells can direct the fate of either populations, for instance immune cells may be recruited to clear senescent cells from aging or cancerous tissues.(55) Considering the increased infiltratio…”
Tang, X., Deng, B., Zang, A., He, X., Zhou, Y., Wang, D., Li, D., Dai, X., Chen, J., Zhang, X., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940577 · Cited by 39
“Given the critical roles of NK cells in immune clearance of senescent cells and their declining activities with aging (25), here we firstly explored whether the administration of autologous NK cells would affect the peripheral population of senescent and exhausted T cells in middle-aged healthy individuals.”
BackgroundGleason, C. E., Dickson, M. A., Klein, M. E., Antonescu, C. R., Gularte‐Mérida, R., Benitez, M., Delgado, J. I., Kataru, R. P., Tan, M. W. Y., Bradić, M., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-2378 · Cited by 43
“The initial recruitment of CD4 þ cells was noted in the earliest studies of oncogene-induced-senescence in mouse liver cancer (20) and probably contributes to the later recruitment of the NK cells that lead to their elimination (61).”
BackgroundTargeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy
Jiang, B., Zhang, W., Zhang, X., & Sun, Y. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.05.002 · Cited by 39
Cellular senescence offers distinct immunological vulnerabilities in cancer
Zhou, L., Ma, B., & Ruscetti, M. A. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.11.010 · Cited by 45
Ji, F., Fu, S., Guo, Z., Pang, H., Chen, D., Wang, X., Ju, W., Wang, D., He, X., Hua, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10848 · Cited by 39
Seebauer, C. T., Brunner, S. M., Glockzin, G., Piso, P., Ruemmele, P., Schlitt, H. J., Geissler, E. K., Fichtner‐Feigl, S., & Kesselring, R. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1242543 · Cited by 41
“Senescent tumor cells have been shown to be subject to enhanced immunosurveillance.(33) In summary, this set of data suggests that PC”
BackgroundAlerting the immune system to DNA damage: micronuclei as mediators
MacDonald, K. M., Benguerfi, S., & Harding, S. M. (2020) · Essays in Biochemistry · doi:10.1042/ebc20200016 · Cited by 43
Schwarzenbach, C., Tatsch, L., Vilar, J. B., Rasenberger, B., Beltzig, L., Kaina, B., Tomicic, M. T., & Christmann, M. (2021) · Cancers · doi:10.3390/cancers13143585 · Cited by 42
“In addition, SASP induces an inflammatory response and activates immune cells, which eliminate senescent tumor cells [19,20].”
BackgroundCellular senescence signaling in cancer: A novel therapeutic target to combat human malignancies
Fakhri, S., Moradi, S. Z., DeLiberto, L. K., & Bishayee, A. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114989 · Cited by 42
Senescence of Tumor Cells in Anticancer Therapy—Beneficial and Detrimental Effects
Piskorz, W. M., & Cechowska‐Pasko, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911082 · Cited by 44
“Senescent cells can, through SASP, activate senescence surveillance—an anticancer immune response in order to inhibit progression of malignant cells [47].”
BackgroundBOK promotes chemical-induced hepatocarcinogenesis in mice
Rabachini, T., Fernández‐Marrero, Y., Montani, M., Loforese, G., Sladky, V. C., He, Z., Bachmann, D., Wicki, S., Villunger, A., Stroka, D., et al. (2017) · Cell Death and Differentiation · doi:10.1038/s41418-017-0008-0 · Cited by 39
“Interestingly, p21 and p19 activation may also be involved in senescence induction, which is another well-described tumor suppressive mechanism through which pre-malignant senescent hepatocytes are subjected to immune cell-mediated clearance [4].”
Wang, H., Tsung, A., Mishra, L., & Huang, H. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105031 · Cited by 42
“4,5,65 Tregs inhibit the function of these anti-malignant Th1 cells, thus impairing immunosurveillance in the MASH liver.”
BackgroundFOXQ1 regulates senescence-associated inflammation via activation of SIRT1 expression
Wang, P., Lv, C., Zhang, T., Liu, J., Yang, J., Guan, F., & Hong, T. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.340 · Cited by 43
“Besides, SASP factors can also promote the immune surveillance of senescent cells by stimulating the immune system to clear premalignant senescent cells and facilitate tissue repair.(11,12) Nevertheless, SASP may promote inflammation and exert a pro-proliferative activity, thus contributing to cancer initiation and pr…”
BackgroundThe SCN 9A channel and plasma membrane depolarization promote cellular senescence through Rb pathway
Warnier, M., Flaman, J., Chouabe, C., Wiel, C., Gras, B., Griveau, A., Blanc, E., Foy, J., Mathot, P., Saintigny, P., et al. (2018) · Aging Cell · doi:10.1111/acel.12736 · Cited by 39
“We then used a model of OIS in human epithelial cells, a model we have extensively characterized (Lallet-Daher et al., 2013; Wiel et al., 2014, 2016).”
BackgroundMethodMarongiu, F., & DeGregori, J. V. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13275 · Cited by 43
Hanning, J. E., Saini, H. K., Murray, M. J., Caffarel, M. M., van Dongen, S., Ward, D. M., Barker, E. M., Scarpini, C. G., Groves, I. J., Stanley, M., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4244 · Cited by 41
“In view of our evidence of senescence induction, we interrogated our microarray data to examine for upregulation of the senescence-associated secretory phenotype (SASP) [27], which can recruit innate immune cells able to clear senescent cells [28,29].”
MethodInsights into the role of senescence in tumor dormancy: mechanisms and applications
DeLuca, V. J., & Saleh, T. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10082-6 · Cited by 41
Senescence in cancer: Advances in detection and treatment modalities
Billimoria, R., & Bhatt, P. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115739 · Cited by 38
Contribution of viral and bacterial infections to senescence and immunosenescence
Reyes, A., Ortiz, G., Duarte, L. F., Fernández, C., Hernández‐Armengol, R., Palacios, P. A., Prado, Y., Andrade, C. A., Rodríguez‐Guilarte, L., Kalergis, A. M., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1229098 · Cited by 39
“Thus, overall, HCV infection likely elicits an increase in senescent T cells that may predispose the individual to the development of HCC, as these T cells would not able to eliminate premalignant senescent hepatocytes (Kang et al., 2011).”
BackgroundLi, W., Kawaguchi, K., Tanaka, S., He, C., Maeshima, Y., Suzuki, E., & Toi, M. (2023) · Communications Biology · doi:10.1038/s42003-023-05433-6 · Cited by 40
“Similarly, senescence inhibits tumor progression by enhancing the anti-tumor immune response 12,13 .”
Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion
Leontieva, O. V., & Blagosklonny, M. V. (2014) · Oncotarget · doi:10.18632/oncotarget.3011 · Cited by 40
“In contrast, in senescent cells, mTOR is active [26, 29, 30, 33, 37- 40] Senescent cells are characterized by a large flat morphology (hypertrophy), active metabolism, differentiation-specific hyperfunctions, and irreversible loss of proliferative potential [21, 23, 39, 41-58].”
BackgroundHBV Infection and Hepatocellular Carcinoma
Iavarone, M. A., & Colombo, M. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.05.002 · Cited by 37
Rosemblit, C., Datta, J., Lowenfeld, L., Xu, S., Basu, A. B., Kodumudi, K. N., Wiener, D. A., & Czerniecki, B. J. (2018) · Oncotarget · doi:10.18632/oncotarget.25208 · Cited by 39
Senescence induction universally activates transposable element expression
Colombo, A. R., Elias, H. K., & Ramsingh, G. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1502576 · Cited by 36
Su, Y., Xu, C., Sun, Z., Liang, Y., Li, G., Tong, T., & Chen, J. (2019) · Aging · doi:10.18632/aging.101760 · Cited by 42
“For instance, SASP has tumor suppressive roles either via cell autonomous mechanism to reinforce cell senescence [2], or using ‘immune surveillance’ mechanism via cell non-autonomous fashion [3].”
The aged liver: Beyond cellular senescence
Allaire, M., & Gilgenkrantz, H. (2019) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2019.07.011 · Cited by 41
Ageing, cellular senescence and the impact of diet: an overview
Maduro, A. I., Luís, C., & Soares, R. A. (2021) · Porto Biomedical Journal · doi:10.1097/j.pbj.0000000000000120 · Cited by 38
“Themajor function of the SASP is to recruit the immune system to destroy senescent cells, by stimulation of adaptive and innate immune cells.(33) On the other hand, factors secreted by senescent cells can drive both differentiated cells and stem cells into the senescent phenotype, exacerbating the cellular senescence…”
Background
Metadata
- Authors
- Kang, T.-W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., Iken, M., Vucur, M., Weiss, S., Heikenwalder, M., Khan, S., Gil, J., Bruder, D., Manns, M., Schirmacher, P., Tacke, F., Ott, M., Luedde, T., Longerich, T., Kubicka, S., & Zender, L.
- Affiliations
- Helmholtz Centre for Infection Research (DE)
- Medizinische Hochschule Hannover (DE)
- Center for Experimental and Clinical Infection Research (DE)
- Universitätsklinikum Aachen (DE)
- Imperial College London (GB)
- Heidelberg University (DE)
- Kreiskliniken Reutlingen (DE)
- Corresponding author
- Zender, Lars
- ORCID
- Venue
- Nature
- Published
- 2011-11
- Volume
- 479
- Issue
- 7374
- Pages
- 547-551
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2042140414
- Cited by
- 1,621
- References
- 22
- Citations by year
- 2026: 93 · 2025: 127 · 2024: 154 · 2023: 140 · 2022: 148 · 2021: 139 · 2020: 137 · 2019: 103 · 2018: 110 · 2017: 99 · 2016: 84 · 2015: 78 · 2014: 72 · 2013: 84 · 2012: 49
- FWCI
- 45.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- oncogene-induced senescence, cellular senescence, hepatocytes, hepatocellular carcinoma, tumor surveillance, CD4+ T cells, tumor antigens, Th1 cells, monocytes/macrophages, tumor suppression, cancer prevention, cancer vaccines
- MeSH terms
- Animals, Antigens, Neoplasm, Carcinoma, Hepatocellular, Humans, Immunologic Surveillance, Liver, Liver Neoplasms, Phagocytosis, Precancerous Conditions, Genes, ras, CD4-Positive T-Lymphocytes, Mice, SCID, Cellular Senescence, Disease Progression, Cancer Vaccines, Hepatocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.